ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 27 filers reported holding ELEVATION ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,453 | -56.2% | 21,813 | +0.4% | 0.06% | -42.1% |
| Q2 2023 | $33,022 | -74.6% | 21,725 | -68.2% | 0.10% | -71.0% |
| Q1 2023 | $129,815 | +100.3% | 68,324 | 0.0% | 0.33% | +97.6% |
| Q4 2022 | $64,800 | -15.8% | 68,324 | +0.0% | 0.17% | +14.5% |
| Q3 2022 | $77,000 | -19.8% | 68,297 | +0.0% | 0.14% | +12.4% |
| Q2 2022 | $96,000 | -44.2% | 68,293 | +0.0% | 0.13% | -39.7% |
| Q1 2022 | $172,000 | -48.3% | 68,279 | +23.5% | 0.21% | -21.3% |
| Q4 2021 | $333,000 | -11.2% | 55,299 | +14.8% | 0.27% | -10.5% |
| Q3 2021 | $375,000 | -30.2% | 48,183 | +21.7% | 0.30% | -17.4% |
| Q2 2021 | $537,000 | – | 39,586 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,370,142 | $2,678,000 | 3.89% |
| Aisling Capital Management LP | 2,834,910 | $3,203,000 | 2.13% |
| venBio Partners LLC | 1,866,339 | $2,109,000 | 0.49% |
| Samsara BioCapital, LLC | 830,565 | $939,000 | 0.22% |
| TCG Crossover Management, LLC | 555,000 | $627,000 | 0.19% |
| Cormorant Asset Management, LP | 1,952,032 | $2,206,000 | 0.15% |
| CAXTON CORP | 68,297 | $77,000 | 0.14% |
| Sio Capital Management, LLC | 359,731 | $406,000 | 0.13% |
| BVF INC/IL | 2,312,200 | $2,613,000 | 0.11% |
| Marquette Asset Management, LLC | 38,951 | $44,000 | 0.01% |